Last updated June 26, 2026

Ditto Biosciences

Discovering autoimmune-disease drugs from parasite immune-evasion biology.

ImmunologyDrug discoveryTherapeutics

Autoimmune diseases occur when the immune system attacks the body’s own tissues, creating chronic inflammation and long-term damage. Many existing treatments suppress immunity broadly, which can increase infection risk and still leave some patients poorly controlled.

Ditto Biosciences is discovering autoimmune-disease drugs from parasite immune-evasion biology. Its approach uses strategies evolved by parasites and other organisms to identify proteins that may retrain immune responses more precisely.

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.